Respiratory comorbidities in severe asthma: focus on the pediatric age

Expert Rev Respir Med. 2023 Jan;17(1):1-13. doi: 10.1080/17476348.2023.2168261. Epub 2023 Jan 17.

Abstract

Introduction: Asthma comorbidities are a frequent cause of adverse outcomes, such as poor asthma control, frequent asthma attacks, reduced quality of life, and higher healthcare costs. Comorbidities are well-known treatable traits whose proper management can help achieve optimal asthma control. Although multimorbidity is frequent among asthmatics, comorbidities are still a potential cause of misdiagnosis and under or over treatments, and little is known about their impact on severe pediatric asthma.

Areas covered: We provided a comprehensive, 5-year updated review focusing on the main respiratory comorbidities in severe asthma, particularly in epidemiology, pathogenesis, and current and future therapies.

Expert opinion: Respiratory comorbidities have unique characteristics in childhood. Their management must be multidisciplinary, age-specific, and integrated. Further longitudinal studies are needed to understand better the mutual interrelation and synergistic effect between asthma and its respiratory comorbidities, the identification of common, treatable risk factors leading to potential asthma prevention, the effectiveness of actual and future target-therapies, and the correlation between long-lasting respiratory comorbidities and poor lung function trajectories.

Keywords: Asthma comorbidities; breathing pattern disorders; bronchiectasis; inducible laryngeal obstructions; obstructive sleep apnea; pediatrics; rhinitis; rhinosinusitis; severe asthma; severe asthma with fungal sensitization.

MeSH terms

  • Asthma* / diagnosis
  • Asthma* / epidemiology
  • Asthma* / therapy
  • Child
  • Comorbidity
  • Humans
  • Lung
  • Quality of Life*
  • Risk Factors